Related Experiment Video
Updated: Dec 2, 2025
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
851
Harnessing Genomic Stress for Antitumor Immunity
Congying Pu1,2, Siyao Tao1,2, Jun Xu1,2
1Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Antioxidants & Redox Signaling
|November 4, 2020
Summary
Genomic instability in cancer can be harnessed to boost antitumor immunity. Understanding these mechanisms offers new therapeutic strategies for cancer treatment by targeting the tumor microenvironment.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Genomic instability is a key cancer hallmark, leading to DNA damage and impacting the tumor microenvironment.
- Cancer cells' susceptibility to genomic stress presents both challenges and therapeutic opportunities.
Purpose of the Study:
- To explore the intricate relationship between genomic stress and antitumor immunity.
- To elucidate mechanisms by which genomic stress can be leveraged to enhance cancer treatment strategies.
Main Methods:
- Review of existing literature on genomic instability, DNA damage response, and immune signaling in cancer.
- Analysis of molecular pathways connecting genomic stress to immune modulation.
Main Results:
- Genomic stress influences antitumor immunity through DNA damage response, immune ligand modulation, DAMP release, neoantigen generation, and DNA sensing pathways.
- Harnessing genomic stress can revive antitumor immunity, offering novel therapeutic avenues.
Conclusions:
- A deeper understanding of genomic stress-immune crosstalk is crucial for developing effective cancer immunotherapies.
- Future research must address cancer heterogeneity and optimize genomic stress inducers for therapeutic benefit.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
1.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.1K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
02:53Adaptive Mechanisms in Cancer Cells
6.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.5K
02:57Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
02:40Cancer Stem Cells and Tumor Maintenance
5.5K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.5K
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K